In a letter dated Thursday (January 26), Rubio said, "An investigative report suggests that Pfizer may be conducting gain-of-function research, which it dubs “directed evolution” research to mutate the SARS-CoV-2 virus to create additional, more potent variants and vaccines to combat future variants."